The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey

被引:58
|
作者
Molteni, Mauro [1 ]
Friz, Hernan Polo [1 ]
Primitz, Laura [1 ]
Marano, Giuseppe
Boracchi, Patrizia
Cimminiello, Claudio [1 ]
机构
[1] Vimercate Hosp, Div Internal Med, Dept Med, I-20871 Vimercate, Italy
来源
EUROPACE | 2014年 / 16卷 / 12期
关键词
Atrial fibrillation; Valvular; Non-valvular; Anti-thrombotic therapy; Stroke; Survey; 2010 ESC GUIDELINES; EUROPEAN-SOCIETY; MEMBER COUNTRIES; WARFARIN; MANAGEMENT; RIVAROXABAN; DABIGATRAN; APIXABAN; STROKE;
D O I
10.1093/europace/euu178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess different aspects of the definition of valvular/non-valvular atrial fibrillation (AF) used in clinical practice by physicians who usually treat this condition. Methods and results We prospectively conducted a web-based survey including cardiologists and internists who attended continuing medical education courses on cardiovascular medicine. A questionnaire was drawn up, containing 17 questions clustered into five main topics: (A) known rheumatic aetiology; (B) site/type of valve involvement; (C) prosthetic heart valve; (D) haemodynamic relevance; (E) miscellaneous. The overall response rate was 22.4%(21.1% for cardiologists and 24% for internists). Coexistence of both medical history of rheumatic disease and clinical signs of valvular involvement were considered as essential prerequisites for the diagnosis of rheumatic AF by half of the respondents, and one-third assumed that lone aortic valve disease was sufficient for AF to be defined as valvular. A similar proportion of respondents considered that in the presence of mitral regurgitation, AF had to be defined as valvular. The majority of responding physicians considered the degree of valvular defect of lesser importance for the definition of valvular or non-valvular origin of AF. Conclusion We found important heterogeneity and uncertainties in the answers given by physicians who usually treat patients with AF, as evidence of the lack of precise and unique definitions of the origin of AF (valvular/non-valvular). It is urgent to issue clear widely accepted definitions of the origin of AF, which should improve clinical practice and research.
引用
收藏
页码:1720 / 1725
页数:6
相关论文
共 50 条
  • [41] The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation
    Burnett, Allison
    Tiongson, Jay
    Downey, Ross
    Mahan, Charles E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (09) : 1119 - 1133
  • [42] Balancing the benefits and harms of oral anticoagulation in non-valvular atrial fibrillation
    Lindley, Richard, I
    AUSTRALIAN PRESCRIBER, 2021, 44 (02) : 49 - 52
  • [43] Percutaneous Left Atrial Appendage Closure for Non-Valvular Atrial Fibrillation
    Hara, Hidehiko
    CIRCULATION JOURNAL, 2016, 80 (05) : 1097 - 1099
  • [44] Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation
    Habara, Seiji
    Dote, Keigo
    Kato, Masaya
    Sasaki, Shota
    Goto, Kenji
    Takemoto, Hiroaki
    Hasegawa, Daiji
    Matsuda, Osamu
    EUROPEAN HEART JOURNAL, 2007, 28 (18) : 2217 - 2222
  • [45] Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
    Hwang, Ki Won
    Choi, Jin Hee
    Lee, Soo Yong
    Lee, Sang Hyun
    Chon, Min Ku
    Lee, Jungkuk
    Kim, Hasung
    Kim, Yong-Giun
    Choi, Hyung Oh
    Kim, Jeong Su
    Park, Yong-Hyun
    Kim, June Hong
    Chun, Kook Jin
    Nam, Gi-Byoung
    Choi, Kee-Joon
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [46] Creatinine clearance and inappropriate dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
    Yagi, Naoharu
    Suzuki, Shinya
    Arita, Takuto
    Otsuka, Takayuki
    Semba, Hiroaki
    Kano, Hiroto
    Matsuno, Shunsuke
    Kato, Yuko
    Uejima, Tokuhisa
    Oikawa, Yuji
    Yajima, Junji
    Matsuhama, Minoru
    Yamashita, Takeshi
    HEART AND VESSELS, 2020, 35 (01) : 110 - 117
  • [47] Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry
    Navarro-Almenzar, Begona
    Jose Cerezo-Manchado, Juan
    Caro-Martinez, Cesar
    Garcia-Candel, Faustino
    Flores Blanco, Pedro Jose
    Elvira Ruiz, Gines
    Andreu Cayuelas, Jose Miguel
    Arregui Montoya, Francisco
    Cascales, Almudena
    Lova Navarro, Alejandro
    Garcia Alberola, Arcadio
    Pascual Figal, Domingo Andres
    Bailen Lorenzo, Jose Luis
    Manzano-Fernandez, Sergio
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (12) : 2035 - 2041
  • [48] Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
    Samaras, Athanasios
    Vrana, Eleni
    Kartas, Anastasios
    Moysidis, Dimitrios, V
    Papazoglou, Andreas S.
    Doundoulakis, Ioannis
    Fotos, George
    Rampidis, Georgios
    Tsalikakis, Dimitrios G.
    Efthimiadis, Georgios
    Karvounis, Haralambos
    Tzikas, Apostolos
    Giannakoulas, George
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [49] Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
    Li, Wei-Jia
    Archontakis-Barakakis, Paraschos
    Palaiodimos, Leonidas
    Kalaitzoglou, Dimitrios
    Tzelves, Lazaros
    Manolopoulos, Apostolos
    Wang, Yu-Chiang
    Giannopoulos, Stefanos
    Faillace, Robert
    Kokkinidis, Damianos G.
    WORLD JOURNAL OF CARDIOLOGY, 2021, 13 (04): : 82 - 94
  • [50] Anticoagulant therapy in patients with non-valvular atrial fibrillation: drug choice and dosage adjustment
    Dolgova, E. L.
    Sokolov, I. M.
    Shvarts, Yu. G.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2013, 9 (03) : 292 - 300